Autoimmune Disease Diagnosis Market: Global Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2017 to 2021 and Forecast 2022 to 2028

$ PRICE - $ 3,000.00$ 8,900.00

Autoimmune Disease Diagnosis Market: By Product (Consumables & Assay Kits, Instruments), By Test Type (Routine Laboratory Tests, Inflammatory Markers, Autoantibodies & Immunologic Test, Other Tests), By Disease (Rheumatoid Arthritis, Systemic Lupus Erythematosus, Sjogren’s Syndrome, Thyroiditis, Scleroderma, Other Diseases, By End-user Industry (Clinical Laboratories, Hospitals, Other End Users) and Geography

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Category:

Report

Description

Autoimmune Disease Diagnosis Market size was valued at USD 4,376.3 million in 2021 and is poised to grow at a significant CAGR of 6.5% over 2022-2028. An autoimmune disease develops when autoimmune cells in the body fail to distinguish between self and non-self-cells, resulting in an immunogenic reaction against the body’s own cells. Several scientific and technical advances have resulted in accurate and rapid diagnosis tools for autoimmune diseases. MiRNAs have critical roles in numerous biological processes that regulate innate and adaptive immune cell development, maturation, and activation in adaptive immune systems. The consumables & assay kits segment is anticipated to grow at a significant CAGR over the forecast years owing to increased extensive usage of ATP assays kits in research institutes to measure cell viability and improve drug discovery due to a surge in chronic diseases that requires tumor testing and cell proliferation (in cancer). Moreover, repeated purchase of consumables by pharmaceutical and biotechnology companies anticipated the segment growth. In addition, Market players focus on launching a new product, collaborating, and acquisitions. For instance, In June 2022, Thermo Scientific launched new EliA RNA Pol III and EliA Rib-P blood tests for the diagnosis of Systemic Sclerosis and Systemic Lupus Erythematous.The rising prevalence of the chronic disease is a key factor surge the autoimmune disease diagnosis market revenue in the future. Moreover, rise in funding from public and private organizations for the development of advanced tests and favorable reimbursement policies are a few factors driving the industry’s growth over the forecasting period.

 

Recent Market Developments:

In 2019, PerkinElmer, Inc. received approval from the US FDA EUROIMMUN Anti-Tissue Transglutaminase ELISA to help clinicians confirm or exclude a celiac disease diagnosis.

In 2019, Exagen Inc. (US) extended its agreement with GSK for a third year to drive greater awareness about challenges facing lupus diagnosis and management.

Autoimmune Disease Diagnosis Market

MARKET SUMMARY
-
6.5% CAGR
  • Study Period– 2022 – 2028
  • Base Year– 2021
  • CAGR–  6.5%
  • Largest Market– North America
  • Fastest Growing Market– Europe

Autoimmune Disease Diagnosis Market

  • The report on global autoimmune disease diagnosis market gives historical, current, and future market sizes (US$ Bn) on the basis of product, test type, disease, end user and geography.
  • The autoimmune disease diagnosis market report gives comprehensive outlook across the region with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
Key Players
  • Bio-Rad Laboratories (US)
  • Grifols (Spain)
  • Trinity Biotech (Ireland)
  • Werfen (Spain)
  • HYCOR Biomedical (US)
  • EUROIMMUN AG (Germany)
Autoimmune Disease Diagnosis Market Dynamics

The main drivers boosting the market of autoimmune disease diagnostics in the projected period of 2017-2028 are increased awareness about autoimmune diseases. The increase in autoimmune disease research, as well as government initiatives and assistance to reduce the incidence of a certain disease, are likely to boost the growth of the disease diagnostics market. However, a lack of skilled professionals to operate diagnosis instruments in developing and underdeveloped countries restrains the disease diagnosis market, whereas high capital investment in diagnosis centers, and thus in rural areas where people cannot afford diagnosis services, will pose a challenge to market growth.


Europe Got Significant Share

Autoimmune Disease Diagnosis Market

The Autoimmune Disease Diagnosis market in Europe is expected to have the highest revenue share in 2021 and the same trend is expected over the forecast period owing to several factors such as rising autoimmune disease burden, rising healthcare expenditure, product launches, and the presence of major players across the region. In addition rise in R&D expenditure and favourable reimbursement policies in USA for autoimmune disease diagnosis, the market is expected to grow significantly across the North America region over the forecast years.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Features of the Report

  • The autoimmune disease diagnosis market report provides granular level information about the market size, regional market share, historic market (2017-2021) and forecast (2022-2028)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario.
Autoimmune Disease Diagnosis Market Segmentation


Location

GEOGRAPHY

Frequently Asked Questions

The increase in autoimmune disease research, government initiatives, and assistance to reduce the incidence of autoimmune diseases are likely to boost the growth of the autoimmune disease diagnostics market.

The autoimmune disease diagnostics market will likely strike a 6.5% CAGR through 2028 due to the rapidly rising morbidity and mortality rate.

Thermo Fisher Scientific (US), Siemens (Germany), Abbott (US), Danaher (US), Bio-Rad Laboratories (US), Grifols (Spain), Trinity Biotech (Ireland)


Report

Table Of Content

1. Executive Summary
2. Global Autoimmune Disease Diagnosis Market Introduction
2.1. Global Autoimmune Disease Diagnosis Market – Taxonomy
2.2. Global Autoimmune Disease Diagnosis Market –Definitions
2.2.1. By Product
2.2.2. By Test Type
2.2.3. By Disease
2.2.4. By End User
3. Global Autoimmune Disease Diagnosis Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Autoimmune Disease Diagnosis Market Dynamic Factors – Impact Analysis
3.6. Global Autoimmune Disease Diagnosis Market – Competition Landscape
3.7. Epidemiology
4. Global Autoimmune Disease Diagnosis Market Analysis, 2017-2021 and Forecast, 2022-2028
4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Autoimmune Disease Diagnosis Market, By Product, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.1. Consumables & Assay Kits
5.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Instruments
5.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
6. Global Autoimmune Disease Diagnosis Market, By Test Type, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.1. Routine Laboratory Tests
6.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Inflammatory Markers
6.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Autoantibodies & Immunologic Test
6.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Other Tests
6.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
7. Global Autoimmune Disease Diagnosis Market, By Disease, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.1. Rheumatoid Arthritis
7.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Systemic Lupus Erythematosus
7.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Sjogren’s Syndrome
7.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
7.4. Thyroiditis
7.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.4.3. Market Opportunity Analysis
7.5. Scleroderma
7.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.5.3. Market Opportunity Analysis
7.6. Other Diseases
7.6.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.6.3. Market Opportunity Analysis
8. Global Autoimmune Disease Diagnosis Market, By End User Industry, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.1. Clinical Laboratories
8.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Hospitals
8.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Other End Users
8.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
9. Global Autoimmune Disease Diagnosis Market Forecast, By Region, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.1. North America
9.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.1.3. Market Opportunity Analysis
9.2. Europe
9.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.2.3. Market Opportunity Analysis
9.3. Asia-Pacific
9.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.3.3. Market Opportunity Analysis
9.4. Latin America
9.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.4.3. Market Opportunity Analysis
9.5. Middle East and Africa
9.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.5.3. Market Opportunity Analysis
9.6. Global Autoimmune Disease Diagnosis Market – Opportunity Analysis Index, By Product, By Test Type, By Disease, By End User Industry, and Region, 2022-2028
10. North America Autoimmune Disease Diagnosis Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
10.1. By Product Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Consumables & Assay Kits
10.1.2. Instruments
10.2. By Test Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.2.1. Routine Laboratory Tests
10.2.2. Inflammatory Markers
10.2.3. Autoantibodies & Immunologic Test
10.2.4. Other Tests
10.3. By Disease Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.3.1. Rheumatoid Arthritis
10.3.2. Systemic Lupus Erythematosus
10.3.3. Sjögren’s Syndrome
10.3.4. Thyroiditis
10.3.5. Scleroderma
10.3.6. Other Diseases
10.4. End User Industry Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.4.1. Clinical Laboratories
10.4.2. Hospitals
10.4.3. Other End Users
10.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.5.1. USA
10.5.2. Canada
10.6. North America Autoimmune Disease Diagnosis Market – Opportunity Analysis Index, By Product, By Test Type, By Disease, By End User Industry, and Country, 2022-2028
10.7. North America Autoimmune Disease Diagnosis Market Dynamics – Trends
11. Europe Autoimmune Disease Diagnosis Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
11.1. By Product Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Consumables & Assay Kits
11.1.2. Instruments
11.2. By Test Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.2.1. Routine Laboratory Tests
11.2.2. Inflammatory Markers
11.2.3. Autoantibodies & Immunologic Test
11.2.4. Other Tests
11.3. By Disease Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.3.1. Rheumatoid Arthritis
11.3.2. Systemic Lupus Erythematosus
11.3.3. Sjögren’s Syndrome
11.3.4. Thyroiditis
11.3.5. Scleroderma
11.3.6. Other Diseases
11.4. End User Industry Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.4.1. Clinical Laboratories
11.4.2. Hospitals
11.4.3. Other End Users
11.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.5.1. Germany
11.5.2. UK
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Europe Autoimmune Disease Diagnosis Market – Opportunity Analysis Index, By Product, By Test Type, By Disease, By End User Industry, and Country, 2022-2028
11.7. Europe Autoimmune Disease Diagnosis Market Dynamics – Trends
12. Asia-Pacific Autoimmune Disease Diagnosis Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
12.1. By Product Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Consumables & Assay Kits
12.1.2. Instruments
12.2. By Test Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.2.1. Routine Laboratory Tests
12.2.2. Inflammatory Markers
12.2.3. Autoantibodies & Immunologic Test
12.2.4. Other Tests
12.3. By Disease Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.3.1. Rheumatoid Arthritis
12.3.2. Systemic Lupus Erythematosus
12.3.3. Sjögren’s Syndrome
12.3.4. Thyroiditis
12.3.5. Scleroderma
12.3.6. Other Diseases
12.4. End User Industry Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.4.1. Clinical Laboratories
12.4.2. Hospitals
12.4.3. Other End Users
12.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.5.1. China
12.5.2. India
12.5.3. Japan
12.5.4. ASEAN
12.5.5. Australia & New Zealand
12.5.6. Rest of Asia-Pacific
12.6. Asia-Pacific Autoimmune Disease Diagnosis Market – Opportunity Analysis Index, By Product, By Test Type, By Disease, By End User Industry, and Country, 2022-2028
12.7. Asia-Pacific Autoimmune Disease Diagnosis Market Dynamics – Trends
13. Latin America Autoimmune Disease Diagnosis Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
13.1. By Product Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1. Consumables & Assay Kits
13.1.2. Instruments
13.2. By Test Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.2.1. Routine Laboratory Tests
13.2.2. Inflammatory Markers
13.2.3. Autoantibodies & Immunologic Test
13.2.4. Other Tests
13.3. By Disease Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.3.1. Rheumatoid Arthritis
13.3.2. Systemic Lupus Erythematosus
13.3.3. Sjögren’s Syndrome
13.3.4. Thyroiditis
13.3.5. Scleroderma
13.3.6. Other Diseases
13.4. End User Industry Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.4.1. Clinical Laboratories
13.4.2. Hospitals
13.4.3. Other End Users
13.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Latin America Autoimmune Disease Diagnosis Market – Opportunity Analysis Index, By Product, By Test Type, By Disease, By End User Industry, and Country, 2022-2028
13.7. Latin America Autoimmune Disease Diagnosis Market Dynamics – Trends
14. Middle East and Africa Autoimmune Disease Diagnosis Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
14.1. By Product Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.1.1. Consumables & Assay Kits
14.1.2. Instruments
14.2. By Test Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.2.1. Routine Laboratory Tests
14.2.2. Inflammatory Markers
14.2.3. Autoantibodies & Immunologic Test
14.2.4. Other Tests
14.3. By Disease Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.3.1. Rheumatoid Arthritis
14.3.2. Systemic Lupus Erythematosus
14.3.3. Sjögren’s Syndrome
14.3.4. Thyroiditis
14.3.5. Scleroderma
14.3.6. Other Diseases
14.4. End User Industry Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.4.1. Clinical Laboratories
14.4.2. Hospitals
14.4.3. Other End Users
14.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
14.5.1. Gulf Cooperation Council (GCC) Countries
14.5.2. South Africa
14.5.3. Rest of MEA
14.6. MEA Autoimmune Disease Diagnosis Market – Opportunity Analysis Index, By Product, By Test Type, By Disease, By End User Industry, and Country, 2022-2028
14.7. MEA Autoimmune Disease Diagnosis Market Dynamics – Trends
15. Competition Landscape 
15.1. Strategic Dashboard of Top Market Players
15.2. Company Profiles (Introduction, Financial Analysis, Key Technologies, Key Developments, Strategies, and SWOT Analysis)
15.2.1. Thermo Fisher Scientific (US)
15.2.2. Siemens (Germany)
15.2.3. Abbott (US)
15.2.4. Danaher (US)
15.2.5. Bio-Rad Laboratories (US)
15.2.6. Grifols (Spain)
15.2.7. Trinity Biotech (Ireland)
15.2.8. Werfen (Spain)
15.2.9. HYCOR Biomedical (US)
15.2.10. EUROIMMUN AG (Germany)
16. Research Methodology
17. Key Assumptions and Acronyms

Report

Company Profile

  • Thermo Fisher Scientific (US)
  • Siemens (Germany)
  • Abbott (US)
  • Danaher (US)
  • Bio-Rad Laboratories (US)
  • Grifols (Spain)
  • Trinity Biotech (Ireland)
  • Werfen (Spain)
  • HYCOR Biomedical (US)
  • EUROIMMUN AG (Germany)

Description

Autoimmune Disease Diagnosis Market size was valued at USD 4,376.3 million in 2021 and is poised to grow at a significant CAGR of 6.5% over 2022-2028. An autoimmune disease develops when autoimmune cells in the body fail to distinguish between self and non-self-cells, resulting in an immunogenic reaction against the body’s own cells. Several scientific and technical advances have resulted in accurate and rapid diagnosis tools for autoimmune diseases. MiRNAs have critical roles in numerous biological processes that regulate innate and adaptive immune cell development, maturation, and activation in adaptive immune systems. The consumables & assay kits segment is anticipated to grow at a significant CAGR over the forecast years owing to increased extensive usage of ATP assays kits in research institutes to measure cell viability and improve drug discovery due to a surge in chronic diseases that requires tumor testing and cell proliferation (in cancer). Moreover, repeated purchase of consumables by pharmaceutical and biotechnology companies anticipated the segment growth. In addition, Market players focus on launching a new product, collaborating, and acquisitions. For instance, In June 2022, Thermo Scientific launched new EliA RNA Pol III and EliA Rib-P blood tests for the diagnosis of Systemic Sclerosis and Systemic Lupus Erythematous.The rising prevalence of the chronic disease is a key factor surge the autoimmune disease diagnosis market revenue in the future. Moreover, rise in funding from public and private organizations for the development of advanced tests and favorable reimbursement policies are a few factors driving the industry’s growth over the forecasting period.

 

Recent Market Developments:

In 2019, PerkinElmer, Inc. received approval from the US FDA EUROIMMUN Anti-Tissue Transglutaminase ELISA to help clinicians confirm or exclude a celiac disease diagnosis.

In 2019, Exagen Inc. (US) extended its agreement with GSK for a third year to drive greater awareness about challenges facing lupus diagnosis and management.

ASIA PACIFIC OFFICE

Precision Business Insights, MIG 366, SAI PLAZA, 1st Floor, KPHB Colony, Hyderabad - 500072

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX